Biologics Procedures (SOPPs)
The FDA's Center for Biologics Evaluation and Research (CBER) has published its internal Standard Operating Procedures and Policies (SOPPs) for public access. These documents detail the specific procedures and policies used by CBER staff when performing their official duties.
This affects manufacturers of biological products, regulatory affairs professionals, and legal teams seeking to understand CBER's internal operational framework.
Transparency regarding CBER's internal procedures allows industry participants to anticipate agency workflows and decision-making processes. Understanding these SOPPs may help regulatory teams better prepare submissions and navigate interactions with FDA staff by aligning with the agency's stated administrative protocols. The availability of these documents suggests a commitment to procedural consistency, which may reduce administrative friction during the review lifecycle.
Regulatory and compliance teams should periodically review relevant CBER SOPPs to align internal procedures with the Center's operational expectations. Quality units may use these documents to benchmark internal quality management systems against FDA's internal administrative standards.
These Standard Operating Procedures and Policies (SOPPs) are used by staff in FDA's Center for Biologics Research and Review (CBER) in the performance of their duties. They are made available here to the public because CBER is committed to being as transparent as possible in how it operates.
Open in openFDA / FDA.gov